Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 18;6:300. doi: 10.3389/fvets.2019.00300

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 Setthawongsin, Teewasutrakul, Tangkawattana, Techangamsuwan and Rungsipipat.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Relative mRNA expression of Bcl-2 (A) and Bax (B) in CTVT dogs before treatment (wk0) and during treatment (wk1–2 PT). Relative mRNA expression of Bcl-2 in wk1 lower than wk0 in CTVT dogs treated with VCR. In addition, relative mRNA expression of Bax during treatment lower than wk0 in CTVT dogs treated with VCR-LAP [Friedman repeated measures analysis of variance and Wilcox Signed-Rank test was used to determine the significance of differentiation before (wk0) and during treatment (wk1 and wk2) in each group, ^*p < 0.05]. Relative mRNA expression of Bcl-2 in CTVT dogs treated with VCR lower than VCR-LAP in wk1 significantly (Mann-Whitney U-test was used to determine the significance of differentiation between the conventional and modified combination chemotherapeutic protocols, ^ap < 0.05).